Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Danish study of a modified Atkins diet for medically intractable epilepsy in children: can we achieve the same results as with the classical ketogenic diet?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Perisylvian epileptic network revisited

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Chronic hyponatremia - Why care? A case report

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Visual field defects after temporal lobe resection for epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Unexpected marked seizure improvement in paediatric epilepsy surgery candidates

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Clinical experience with eslicarbazepine acetate in adults with sub-analysis of elderly

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Clinical and genetic spectrum of SCN2A-associated episodic ataxia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The spectrum of intermediate SCN8A-related epilepsy

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Negativ antimyelin oligodendrocyt- glykoproteinantistof hos en dreng med akut demyeliniserende tilstand i centralnervesystemet

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Udredning af krampeanfald i neonatalperioden

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Modified Atkins diet (MAD) is a less restrictive variety of the classical ketogenic diet (KD), used for treating patients with medically resistant epilepsy. There are only few reports comparing the two types of diets in terms of seizure reduction and tolerability. We compared the effect of a MAD evaluated prospectively on 33 consecutive children with medically resistant epilepsy, with a group of 50 patients, previously treated with KD. Patients who had >50% seizure reduction were considered responders. After 3 months on the MAD, 17 patients (52%) were responders, including 14 (42%) who had >90% seizure reduction. After 6 months, 13 patients (39%) were responders. Seventeen patients (52%) remained on the MAD at least 12 months with excellent overall tolerance and compliance, including 9 patients (27%) who were responders, 4 of them (12%) having >90% seizure reduction. Although there was a trend for higher incidence of responders in the KD group, this failed to reach the level of significance: after 6 months 39% on MAD and 60% on KD were responders. However, this trend was not observed when the two groups were adjusted for difference in age (patients in the MAD group were older than the KD group). In conclusion, our experience suggests that the MAD is similarly effective as the KD in reducing seizure frequency in children with medically resistant epilepsy.
OriginalsprogEngelsk
TidsskriftSeizure - European Journal of Epilepsy
Vol/bind20
Udgave nummer2
Sider (fra-til)151-5
Antal sider5
ISSN1059-1311
DOI
StatusUdgivet - mar. 2011

ID: 34699052